Skip to main content
Clinical Trials/CTRI/2020/03/023700
CTRI/2020/03/023700Not yet recruitingPhase 3

The comparative study of the efficacy of topical 0.5% timolol ophthalmic solution and oral propranolol in the treatment of infantile hemangioma

Mahatma Gandhi Mission Ethics Committee for Research on Human Subjects0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • Patient parents willing to undergo treatment and ready to bring the patient for followup.
  • Focal and localized hemangioma.

Exclusion Criteria

  • Patients who have contraindications for beta blockers.
  • Extra cutaneous and multifocal hemangioma.

Investigators

Sponsor
Mahatma Gandhi Mission Ethics Committee for Research on Human Subjects

Similar Trials

Study to compare effects of timolol eye... | Clinical Trial